<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139685">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02081482</url>
  </required_header>
  <id_info>
    <org_study_id>13-AOI-05</org_study_id>
    <nct_id>NCT02081482</nct_id>
  </id_info>
  <brief_title>Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation</brief_title>
  <acronym>MET-ONS</acronym>
  <official_title>Study of the Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The occipital nerve stimulation (ONS) is used to treat patients with refractory primary
      chronic headache but its mechanism of action (MoA) remains unknown. Different hypothesis
      have been suggested in particular a specific action on cerebral generators involved in
      different types of primary headaches or a non specific action on pain modulatory network.

      The aim of this study, using the chronic cluster headache as a model, is to determine the
      changes in cerebral metabolism induced by ONS to precise its MoA in the treatment of primary
      chronic headache.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Comparison of cerebral metabolism</measure>
    <time_frame>Baseline (before ONS), 1 week after ONS , 3 month after ONS</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes of cerebral metabolism associated with ONS efficacy</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Refractory Chronic Cluster Headache</condition>
  <arm_group>
    <arm_group_label>subjects with refractory chronic cluster headache</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adult subjects with refractory chronic cluster headache and ONS indication</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>18F-FDG PET</intervention_name>
    <arm_group_label>subjects with refractory chronic cluster headache</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  chronic cluster headache (according to the IHS)

          -  refractory in who a treatment by ONS have been indicated

          -  patient affiliated at social security,

          -  informed consent signed

        Exclusion Criteria:

          -  contraindication to MRI

          -  contraindication to 18F-FDG PET

          -  women without contraception/pregnant/breast-feeding

          -  patient non-compliant

          -  patient on legal guardianship
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michel LANTERI-MINET, PH</last_name>
    <phone>33 (0)4-92-03-79-46</phone>
    <email>lanteri-minet.m@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sylvie ROMETTINO, CRA</last_name>
    <email>romettino.s@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU -Hôpital Gabriel Montpied</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vanina OLIVERI, CRA</last_name>
      <phone>0033 4 92 03 42 54</phone>
      <email>oliveri.v@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Denis Jacques SINARDET, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut des Neurosciences</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vanina OLIVERI, CRA</last_name>
      <phone>0033 4 03 42 54</phone>
      <email>oliveri.v@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Anne DONNET, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Evaluation et Traitement de la Douleur - Pôle Neurosciences Cliniques - Centre Hospitalo-Universitaire de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vanina OLIVERI, CRA</last_name>
      <phone>0033 4 92 03 42 54</phone>
      <email>oliveri.v@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Michel LANTERI-MINET, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denys FONTAINE, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'Urgence Céphalées</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vanina OLIVERI, CRA</last_name>
    </contact>
    <investigator>
      <last_name>Béchir JARRAYA, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 10, 2014</lastchanged_date>
  <firstreceived_date>March 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cluster Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
